IL-6 and TNF-α in unmedicated adults with ADHD: Relationship to cortisol awakening response

[1]  J. Ramos-Quiroga,et al.  Cortisol awakening response in adults with attention deficit hyperactivity disorder: Subtype differences and association with the emotional lability , 2016, European Neuropsychopharmacology.

[2]  J. Haavik,et al.  Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study , 2015, Behavioral and Brain Functions.

[3]  F. Balcı,et al.  TNF-alpha inhibition prevents cognitive decline and maintains hippocampal BDNF levels in the unpredictable chronic mild stress rat model of depression , 2015, Behavioural Brain Research.

[4]  D. Wack,et al.  Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder , 2015, PloS one.

[5]  J. Sunyer,et al.  New suggestive genetic loci and biological pathways for attention function in adult attention‐deficit/hyperactivity disorder , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  J. Ramos-Quiroga,et al.  Cortisol Response to Stress in Adults with Attention Deficit Hyperactivity Disorder , 2015, The international journal of neuropsychopharmacology.

[7]  Young T. Hong,et al.  Dissociable Rate-Dependent Effects of Oral Methylphenidate on Impulsivity and D2/3 Receptor Availability in the Striatum , 2015, The Journal of Neuroscience.

[8]  G. Salum,et al.  Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[9]  O. Mors,et al.  Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. , 2014, JAMA psychiatry.

[10]  Georgia E. Hodes,et al.  Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress , 2014, Proceedings of the National Academy of Sciences.

[11]  J. Cidlowski,et al.  One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids , 2014, Neuroimmunomodulation.

[12]  K. Kirkby,et al.  The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. , 2014, Psychiatria Danubina.

[13]  R. Joseph,et al.  Elevated blood levels of inflammation-related proteins are associated with an attention problem at age 24 mo in extremely preterm infants , 2014, Pediatric Research.

[14]  M. Bayés,et al.  Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. , 2014, Journal of psychiatric research.

[15]  정성훈.  DIAGNOSTIC AND STATISTIC MANUAL OF MENTAL DISORDERS , 2013 .

[16]  C. Sánchez-Mora,et al.  Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. , 2013, The international journal of neuropsychopharmacology.

[17]  Veit Roessner,et al.  Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder , 2013, Psychoneuroendocrinology.

[18]  J. Thome,et al.  Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels , 2012, Molecular Psychiatry.

[19]  S. Bilbo,et al.  The immune system and developmental programming of brain and behavior , 2012, Frontiers in Neuroendocrinology.

[20]  T. Seeman,et al.  Associations of salivary cortisol levels with inflammatory markers: The Multi-Ethnic Study of Atherosclerosis , 2012, Psychoneuroendocrinology.

[21]  B. McEwen.  The ever‐changing brain: Cellular and molecular mechanisms for the effects of stressful experiences , 2012, Developmental neurobiology.

[22]  R. Oades,et al.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication , 2010, Behavioral and Brain Functions.

[23]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[24]  E. Maldonado,et al.  Salivary Cortisol Response to a Psychosocial Stressor on Children Diagnosed with Attention-Deficit/Hyperactivity Disorder: Differences Between Diagnostic Subtypes , 2009, The Spanish journal of psychology.

[25]  Martin Samuelsson,et al.  Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity , 2009, Biological Psychiatry.

[26]  J. Ramos-Quiroga,et al.  Validación al español de la escala de cribado del trastorno por déficit de atención/hiperactividad en adultos (ASRS v. 1.1):: una nueva estrategia de puntuación , 2009 .

[27]  S. Claes,et al.  Differences in hypothalamic–pituitary–adrenal axis functioning among children with ADHD predominantly inattentive and combined types , 2009, European Child & Adolescent Psychiatry.

[28]  M. Devoto,et al.  ADHD genetics: 2007 update , 2007, Current psychiatry reports.

[29]  E. Fernell,et al.  Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder. , 2007, European journal of oral sciences.

[30]  E. Remor,et al.  Psychometric Properties of a European Spanish Version of the Perceived Stress Scale (PSS) , 2006, The Spanish Journal of Psychology.

[31]  S. Faraone,et al.  Attention-deficit hyperactivity disorder , 2005, The Lancet.

[32]  J. Francis,et al.  Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia , 2005, Physiology & Behavior.

[33]  W. Roberts,et al.  Replication Test for Association of the IL-1 Receptor Antagonist Gene, IL1RN, with Attention-Deficit/Hyperactivity Disorder , 2004, Neuropsychobiology.

[34]  J. Buitelaar,et al.  Stress responsivity in children with externalizing behavior disorders , 2004, Development and Psychopathology.

[35]  E. Sternberg,et al.  Neuroendocrine regulation of immunity. , 2003, Annual review of immunology.

[36]  C. Kirschbaum,et al.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change , 2003, Psychoneuroendocrinology.

[37]  Eun Ha Lee,et al.  Hypothalamic-pituitary-adrenal reactivity in boys with attention deficit hyperactivity disorder. , 2003, Yonsei medical journal.

[38]  S. Handley,et al.  Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder. , 2002, Neuro endocrinology letters.

[39]  George P. Chrousos,et al.  Plasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder , 2002, Neuroimmunomodulation.

[40]  M. Sawyer,et al.  Validity of DSM-IV ADHD subtypes in a nationally representative sample of Australian children and adolescents , 2001 .

[41]  C. Gillberg,et al.  Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[42]  S. Maier,et al.  Timecourse and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1β protein response to acute stress , 2000, Brain Research.

[43]  J. Levine,et al.  Cerebrospinal Cytokine Levels in Patients with Acute Depression , 1999, Neuropsychobiology.

[44]  J. King,et al.  Attention-deficit hyperactivity disorder and the stress response , 1998, Biological Psychiatry.

[45]  P. Deuster,et al.  Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .

[46]  J. Kagan,et al.  A 3-year follow-up of children with and without behavioral inhibition. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[47]  R. Oades,et al.  ResearchAttention-deficit hyperactivity disorder ( ADHD ) and glial integrity : an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention , 2015 .

[48]  A. Darvasi,et al.  Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder , 2002, Molecular Psychiatry.

[49]  A. Turnbull,et al.  Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. , 1999, Physiological reviews.

[50]  E. Aardal,et al.  Cortisol in Saliva - Reference Ranges and Relation to Cortisol in Serum , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.